The Ebola Breakout Coincided With UN Vaccine Campaigns

The mystery at the heart of the ebola outbreak is how the 1995 Zaire (ZEBOV) strain, which originated in Central Africa some 4,000 km to the east in Congolese (Zairean) provinces of Central Africa, managed to suddenly resurface now a decade later in Guinea, West Africa. Since no evidence of ebola infections in transit has been detected at airports, ports or highways, the initial infections must have come from one of either two alternative routes:
     
  - First, the possibility of an anonymous “Patient A”, a survivor of the devastating 1995 Zaire pandemic, perhaps a doctor or medical worker who was a carrier of the dormant virus into Guinea. An example of a Patient A is Patrick Sawyer, the infected American resident of Liberia who first transmitted ebola to Nigeria. No attempt has been made by the national health ministry or international agencies to trace and identify the original ebola case in Guinea. So far, not a shred of evidence has surfaced to indicate the very first victim to be a foreigner or a Guinean who had traveled abroad.
     
  - Second, the absence of a Patient A leaves the prospect of an unauthorized test in humans of a new antidote for ebola in rural Guinea, done under the cover of a vaccination program for another disease. Whether the covert clinical trial’s purpose was civilian health or military use of an antibody-based antidote cannot be determined as of yet.
     
 The reason for suspecting a vaccine campaign rather than an individual carrier is due to the fact that the ebola contagion did not start at a single geographic center and then spread outward along the roads. Instead simultaneous outbreaks of multiple cases occurred in widely separated parts of rural Guinea, indicating a highly organized effort to infect residents in different locations in the same time-frame. http://www.liberianobserver.com/commentaries/ebola-breakout-coincided-un-vaccine-campaigns